Issue link: https://viewer.e-digitaledition.com/i/133409
++++++++++++++++++ + +++ +LEGAL EASE U +++ ++++++++++++++++++ New Studies, the Standard of Care and Malpractice Claims By Nancy J. Block M ALPRACTICE OCCURS WHEN treatment falls short of the standard of care. This raises the questions, "Who determines what the standard of care is? Physicians? Government? Insurance companies? If treatment or testing is not covered by insurance, does this mandate that such testing is not the standard of care? Should the corollary then follow that when treatment or testing is covered by insurance, the minimum standard-ofcare requirements are met? Clearly, we can agree insurance coverage does not set the standard of care at present, but what about in the future?" These questions may affect women's health care and, in turn, the malpractice industry. Late last year, The New England Journal of Medicine published a study suggesting mammography had contributed to an overdiagnosis of early-stage cancers but had only marginally reduced the diagnosis of advanced cancer. The implication is that mammography as an early-detection mechanism is not statistically successful. Not surprisingly, this notion is highly emotional and controversial — and since the study was published, there has been much debate about the appropriateness and efficacy of screening mammograms. It is also perhaps not surprising that plaintiff malpractice attorney websites cite the study to heighten awareness of the harm of overly aggressive treatment for potential malignancy. Some of these websites suggest the Affordable Care Act 12 | Lower Hudson/Bronx MD NEWS I MDNEWS.COM has led to a reliance on evidence-based studies for establishing best practices in medicine. The questions then become, "If evidence-based medicine and the consensus are against certain screening mammograms, will these tests no longer be covered by insurance, and thus no longer be deemed the standard of care? If this is the case, will a physician be able to rely on such studies as a shield against malpractice lawsuits?" Although fairness may support such rationale, reality does not. Claims that earlier detection was possible are essential to virtually all cases alleging failure to timely diagnose cancer. And, notably, the same websites do not suggest screening mammograms are unnecessary. They focus only on the consideration that treatment may be too aggressive, e.g. unnecessary mastectomies, etc. In March, The New York Times reported on a new study led by researchers in Irvine, CA, about ovarian cancer. According to the study, women with ovarian cancer are drastically undertreated. This study, too, was immediately picked up by plaintiff malpractice attorneys, who suggested a possible increase in malpractice claims due to the flaws in ovarian cancer treatment. According to the Times, the unpublished study analyzed medical records of more than 13,000 women from 1999 to 2006 and determined that more than 80% of women were treated by low-volume providers — surgeons with 10 or fewer cases and hospitals with 20 or fewer cases — and were substantially undertreated. The study acknowledged that most ovarian cancers are diagnosed only in the advanced stage. As a result, it is critical to treat, as per the guidelines set by the National Comprehensive Cancer Network, with surgery and chemotherapy, depending on the stage. The study emphasized the importance of specialty care at facilities that have gynecologic oncologists with familiarity and experience. Again, this sentiment was echoed by plaintiff malpractice attorneys with the suggestion that it is the experienced physician, and only the experienced physician, who should treat patients with an ovarian cancer diagnosis. Thus, for a physician who is considered a low-volume provider, good practice suggests referral to a more specialized and experienced physician — and, from a medicolegal perspective, documentation of this referral is best. What constitutes the standard of care has changed throughout history. Certainly, President James Garfield would have preferred if Listerian concepts had been embraced by his surgeons as the standard of care. For today, it remains to be seen what will have the greatest influences going forward. Regardless, it is always prudent to be cognizant of the changes in law and opinion that may sway the direction of medicine. Nancy J. Block is a senior partner with Martin Clearwater & Bell LLP. For more information about the firm, please visit www.mcblaw.com. I

